在患有严重喘的患者中,埃索诺菲利亚的决定因素
Racha Abi Melhem1, Marc Assaad2, Khalil El Gharib1
1Department of Medicine, Staten Island University Hospital, Staten Island, NY 10305, USA.
Journal of clinical medicine research
|May 8, 2024
概括
与非乙酸性喘 (NEA) 相比,乙酸性喘 (EA) 患者表现出明显的临床特征和并发症. 确定EA对于有针对性的治疗和改善喘管理至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 过敏和临床免疫学
背景情况:
- 喘是一种异质性疾病,由慢性呼吸道炎症定义,具有明显的免疫路径.
- 喘亚型包括乙酸性喘 (EA) 和非乙酸性喘 (NEA),不同于招募的细胞和互白素配置文件.
- EA患者往往对吸入性皮质类固醇的反应比NEA患者更好,这凸显了针对性治疗的亚型识别的重要性.
研究的目的:
- 分析严重的酸性喘 (EA) 与非酸性喘 (NEA) 的临床特征和结果.
- 为了比较EA和NEA之间的慢性类固醇使用,并发症和医疗保健资源利用率的流行率.
- 评估区分EA对于指导治疗策略和管理严重喘的重要性.
主要方法:
- 从全国住院患者数据库 (2018) 中对2,646名成人严重喘患者进行了回顾性队列分析.
- 分层分为酸性严重喘 (n=882) 和非酸性严重喘 (n=1,764) 组.
- 通过使用统计测试 (t-test,曼-惠特尼U,Chi-square) 来比较主要结局,包括类固醇使用,喘状态,过敏,息肉存在,通风需求,死亡率和停留时间.
主要成果:
- 乙酸性喘患者的慢性类固醇使用率显着更高 (18.3%与9.5%相比),喘状况和积极的家族病史.
- 在eosinophilic组中观察到过敏,过敏性鼻炎,鼻和过敏性皮肤炎的患病率增加.
- 在EA患者中,机械通风和氧补充的需求更高,死亡率或住院时间没有显著差异.
结论:
- 乙酸性喘在临床上是截然不同的,其特点是增加的亚托皮,并发症和可能不同的症状.
- EA患者可能从类固醇治疗和新兴的T2向免疫疗法中受益.
- 准确识别eosinophilic喘对于优化疾病控制和治疗选择至关重要.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
277
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K